Specify Company / Ticker to Get the Summary
Dividend History ACXP
Dividend Analytics ACXP
Max Ratio
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Acurx Pharmaceuticals LLC
ACXPAcurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York. Address: 259 Liberty Avenue, Staten Island, NY, United States, 10305
Analytics
WallStreet Target Price
5.70 USDP/E Ratio
–Dividend Yield
–Financials ACXP
Results | 2019 | Dynamics |